Guidelines for the inclusion of pathology in clinical trial protocols: SPIRIT-Path

An international group of cancer researchers, led by the National Cancer Research Institute's (NCRI) Cellular Molecular Pathology Initiative (CMPath), has published guidance to address the variability in how pathology is planned and delivered in clinical trials.

source https://medicalxpress.com/news/2021-09-guidelines-inclusion-pathology-clinical-trial.html